New robotic system could revolutionize treatment of multi-site conditions

Multiple disease sites are common in clinical practice. In the brain for instance, blocked blood vessels can cause strokes, in which the lack of oxygen rapidly damages brain cells. If multiple vessels are blocked, critical areas of the brain may be deprived of blood, leading to severe neurological damage or even death if left untreated. This underscores the urgent need for advanced technologies to treat multi-site conditions.

Magnetically actuated soft robots have significant potential for reaching and treating hard-to-reach areas of the body. They can facilitate targeted drug delivery and support flow diversion. Using multiple robots could allow simultaneous treatment of several locations, saving critical time and enabling localized care.

Scientists at the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart, Germany, have looked at this problem. They have developed a robotic system which deploy tiny robots five millimeters in size which deliver drugs or redirect the fluid flow at multiple locations inside a 3D lumen network, which very much resembles a network of real blood vessels. In a paper published in Science Advances, the team from the Physical Intelligence Department shows how multiple robots are independently controlled to navigate tortuous lumens and conduct their functions simultaneously.

The controlled object is a magnetic robot in the shape of a stent, designed to flexibly adapt to changes in the lumen. To navigate through the network of lumens, the robot needs a strong magnetic force to overcome friction and fluid flow. If the force is insufficient, the robot is unable to move forward. By reducing the magnetic force on unwanted robots while increasing it on the desired robot, one robot can be enabled to move while the others remain stationary.

"To our knowledge, this is the first case of independent control of more than five robots in 3D lumens under physiologically relevant conditions," says Chunxiang Wang, a Ph.D. student in the Physical Intelligence Department at MPI-IS and first author of the paper "Heterogeneous Multiple Soft Millirobots in Three-dimensional Lumens". On November 6, 2024, the research study was published as a featured article in Science Advances.

The robot is controlled by a rotating permanent magnet, with proposed influence and rotation regions to enhance usability. Placing the magnet outside the influence region disables unwanted robots, while positioning it within the actuation region activates the target robot, providing intuitive control for the operator. In practice, the user simply enters the target points and a robotic arm uses a path-planning algorithm to automatically deploy the robots, making the system user-friendly and easy to implement.

For us it was quite a challenge to control multiple magnetic robots all at once – after all, all magnetic parts are affected by the magnetic field in the same way. Our work provides a solution for multi-robot actuation, enhancing applications across various miniature soft robotic device designs in complex environments."

Tianlu Wang, former postdoctoral researcher in the Physical Intelligence Department at MPI-IS and currently Assistant Professor at the University of Hawaiʻi at Mānoa

"The proposed system has the potential to open avenues for a wide range of biomedical applications by deploying a group of soft robots equipped with diverse functional modules to reach hard-to-access areas deep inside the human body for targeted therapy", says Metin Sitti, former Director of the Physical Intelligence Department at MPI-IS and President at Koç University.

Source:
Journal reference:

Wang, C., et al. (2024). Heterogeneous multiple soft millirobots in three-dimensional lumens. Science Advances. doi.org/10.1126/sciadv.adq1951.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes drugs cut asthma attacks by up to 70%, reshaping treatment options